CLINICAL TRIALS PROFILE FOR TAUVID
✉ Email this page to a colleague
All Clinical Trials for TAUVID
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01992380 ↗ | A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects | Completed | Avid Radiopharmaceuticals | Phase 1 | 2013-11-13 | This study will test if two flortaucipir PET scans up to 4 weeks apart in healthy volunteers, MCI and AD subjects provide the same results. |
| NCT02167594 ↗ | Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers | Completed | Avid Radiopharmaceuticals | Phase 1 | 2014-08-12 | This study will evaluate flortaucipir for brain imaging of tau in subjects with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and healthy volunteers. |
| NCT02278354 ↗ | Tau Imaging in Professional Fighters | Completed | The Cleveland Clinic | Phase 1 | 2015-02-18 | Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) will receive flortaucipir to explore its use as a biomarker for brain injury related to repetitive head trauma and to examine the relationship between clinical presentation and tau deposition. |
| NCT02278354 ↗ | Tau Imaging in Professional Fighters | Completed | Avid Radiopharmaceuticals | Phase 1 | 2015-02-18 | Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) will receive flortaucipir to explore its use as a biomarker for brain injury related to repetitive head trauma and to examine the relationship between clinical presentation and tau deposition. |
| NCT02278367 ↗ | Clinical Evaluation of Flortaucipir F 18 | Completed | Avid Radiopharmaceuticals | Phase 2 | 2014-12-01 | This study is designed to expand the database of flortaucipir F 18 safety and tau binding as measured by PET imaging and to provide standardized conditions for flortaucipir PET use, data collection and analysis to facilitate companion studies including, but not limited to, longitudinal studies of aging, depression, and traumatic brain injury. |
| NCT02336360 ↗ | Augmenting Flortaucipir Dosimetry Estimates | Completed | Avid Radiopharmaceuticals | Phase 1 | 2015-01-01 | This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates. |
| NCT03040713 ↗ | Flortaucipir PET Imaging in Subjects With FTD | Completed | Avid Radiopharmaceuticals | Phase 1 | 2017-04-11 | This study is designed to assess the usefulness of flortaucipir in Positron Emission Tomography (PET) imaging for subjects diagnosed with Frontotemporal Dementia (FTD). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TAUVID
Condition Name
Clinical Trial Locations for TAUVID
Trials by Country
Clinical Trial Progress for TAUVID
Clinical Trial Phase
Clinical Trial Sponsors for TAUVID
Sponsor Name
